TAMPA, Fla., Feb. 18, 2016 -- PPJ Healthcare Enterprises Inc. (OTC Pink:PPJE) announced today that it has executed 7l contracts, including Valley Herbal in Los Angeles area, to perform medical marijuana testing. The Company expects to execute a total of 100 contracts over the next 90 days and estimates that it could generate about $20,000 in revenue per dispensary per year.
“The signing of these contracts puts us in the position of being able to hit the ground running when the doors open,” said Chandana Basu, CEO of PPJ Healthcare Enterprises Inc. “The opening of our testing facility coupled with our recently announced pain clinic are significant steps in the Company’s plans to expand our business and work with partners that need key elements that we can offer.”
The Company anticipates the lab could open as early as next 45 to 60 days.
“We are working diligently to grow shareholder value through these continuous partnership opportunities. This strategy will not only allow us to expand at a quicker pace, but allows us to share the expense and risks associated with opening clinics and labs,” Basu said.
Forward-looking Statements
Information in this release may contain statements about future expectations, plans, prospects or performance of PPJ Healthcare Enterprises Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases “can be,” “expects,” “may affect,” “believed,” “estimate,” “project” and similar words and phrases are intended to identify such forward-looking statements. PPJ Healthcare Enterprises cautions you that any forward-looking information provided by or on behalf of PPJ Enterprise is not a guarantee of future performance. None of the information in this press release constituted or is intended as an offer to sell securities or investment advice of any kind. PPJ Healthcare Enterprises’ actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond PPJ Enterprise’s control. In addition to those discussed in PPJ Healthcare Enterprises’ press releases, public filings and statements by PPJ Healthcare Enterprises’ management, including, but not limited to, PPJ Healthcare Enterprises’ estimate of sufficiency of its existing capital resources, PPJ Healthcare Enterprises’ ability to raise additional capital to fund future operations, PPJ Healthcare Enterprises’ ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match PPJ Healthcare Enterprises’ capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. PPJ Healthcare Enterprises does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made to reflect the occurrence of unanticipated events.
PPJ Healthcare Enterprises, Inc.
401 E. Jackson St., Suite 2340
Tampa, Florida 33602
Telephone: (813) 693-5192
Fax: (866) 622-3215
Websites: https://www.ppjenterprise.com
http://ppjenterprisedotorg.wordpress.com
https://www.automatedbiller.com
https://www.professionalbillingservice.net
https://www.facebook.com/PPJEnterprise
https://www.linkedin.com/pub/chandana-basu/76/6a1/137
https://www.twitter.com/PPJEnterprise


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



